News on research grants, RFPs, government funding trends in genetics, genomics, and molecular diagnostics.
The semifinalists will receive $50,000 each to develop prototypes of their concepts for submission in the second phase of the challenge.
The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.
The funding will advance work focused on the discovery of a genomic configuration that correlates to chemotherapy sensitivity.
The collaborators are developing tests for rectal cancer based on microRNA and messenger RNA signatures.
After passing the House of Representatives last week, the legislation is now set to go before President Barack Obama, who said he will sign it into law.
